Keith Humphreys, PhD

Esther Ting Memorial Professor at Stanford University

Abstract

Legalization and decriminalization of cannabis in Norway

Norway recently decriminalised the use of cannabis, and at least some voices are calling for the country to actually legalize the sale and production of the drug.  This presentation reviews what happens when countries implement such policy steps, including how consumption, prices, and harms may change.  Different models of legalization are described, as are the tradeoffs they present.

Patients vs. Subjects: Why so much addiction treatment research doesn’t generalize to clinical practice

Studies of treatments for tobacco, alcohol, and illicit use disorders typically employ exclusion criteria that rule out many — indeed most — patients from enrolling in research.  This presentation describes the extent of this phenomenon, how it limits the utility of clinical research, and the ethical concerns that it raises.

The presentations will be held in english.

About Keith Humphreys

Keith Humphreys is the Esther Ting Memorial Professor at Stanford University. He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto and an Honorary Professor of Psychiatry at the Institute of Psychiatry, King’s College, London.

His research addresses the prevention and treatment of addictive disorders, the formation of public policy and the extent to which subjects in medical research differ from patients seen in everyday clinical practice. He and the authors of «Drug Policy and the Public Good» (including Norwegian scholar Ingeborg Rossow) won the 2010 British Medical Association’s Award for Public Health Book of the Year.

Dr. Humphreys has been extensively involved in the formation of public policy, having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration. During the President Obama’s Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also presented evidence on numerous occasions in the U.K. Parliament.

Les mer om Keith Humphreys